The Registry of Toxic Effects of Chemical Substances
Potassium cyanide |
UPDATE: May 2005 | MW: 65.12 | MF: CKN |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
human
lymphocyte
|
70 mg/L/24 hour
|
MUREAV 537,117,2003
|
cytogenetic analysis
|
mouse
mammary gland
|
1 mmol/L/48 hour
|
MUREAV 67,221,1979
|
DNA damage
|
rat
liver
|
300 µmol/L
|
MUREAV 368,59,1996
|
DNA damage
|
rat
other cell types
|
5 mmol/L/6 hour
|
TOLED5 128,185,2002
|
DNA inhibition
|
mouse
lymphocyte
|
1 mmol/L
|
NEOLA4 28,423,1981
|
DNA repair
|
Escherichia coli
|
39 µg/well
|
MUREAV 133,161,1984
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 45 mg/kg (1-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TJADAB 25(2),84A,1982
|
oral | domestic animal
lowest published toxic dose: 1,767 mg/kg (8-20 week pregnant/44 day after birth)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) | Reproductive: Effects on newborn: Other neonatal measures or effects
RJARAV 16,109,1978
|
oral | rat
lowest published toxic dose: 65 gm/kg (14 day prior to copulation/1-22 day pregnant)
|
Reproductive: Effects on fertility: Other measures of fertility
|
BNEOBV 36,233,1979
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraarterial | guinea pig
lowest published lethal dose: 5 mg/kg
|
N/R
|
AEPPAE 131,171,1928
|
intramuscular | pigeon
lethal dose (50 percent kill): 4 mg/kg
|
N/R
|
JJPAAZ 3,99,1954
|
intramuscular | rat
lowest published lethal dose: 8 mg/kg
|
N/R
|
27ZIAQ -,209,1973
|
intramuscular | rabbit
lethal dose (50 percent kill): 3,256 µg/kg
|
N/R
|
JACTDZ 1(3),120,1982
|
intraperitoneal | guinea pig
lowest published lethal dose: 8 mg/kg
|
N/R
|
CRSBAW 96,202,1927
|
intraperitoneal | mouse
lowest published toxic dose: 10 mg/kg/3 minute
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
VCVN1* -,342,1988
|
intraperitoneal | mouse
lethal dose (50 percent kill): 5.7 mg/kg
|
N/R
|
TOLED5 132,95,2002
|
intraperitoneal | rat
lethal dose (50 percent kill): 4 mg/kg
|
Lung, Thorax, or Respiration: Other changes
|
JAPYAA 32,315,1972
|
intraperitoneal | rat
lowest published toxic dose: 7 mg/kg
|
Ear: Change in cochlear structure or function
|
NETEEC 23,157,2001
|
intraperitoneal | rat
lowest published toxic dose: 2 mg/kg
|
Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum | Biochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNS
FCTOD7 42,605,2004
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 3,972 µg/kg
|
Blood: Other changes
|
TOXID9 3,64,1983
|
intravenous | cat
lethal dose (50 percent kill): 2,200 µg/kg
|
N/R
|
PSEBAA 35,316,1936
|
intravenous | cat
lowest published toxic dose: 1 mg/kg
|
Brain and Coverings: Changes in surface EEG | Cardiac: Arrythmias (indlucing changes in conduction) Lung, Thorax, or Respiration: Respiratory obstruction
EKFAE9 57,60,1994
|
intravenous | dog
lowest published lethal dose: 5 mg/kg
|
N/R
|
27ZIAQ -,209,1973
|
intravenous | domestic animal
lowest published lethal dose: 10 mg(CN)/kg/11 minute
|
N/R
|
VCVN1* -,342,1988
|
intravenous | guinea pig
lowest published lethal dose: 5 mg/kg
|
N/R
|
AEPPAE 131,171,1928
|
intravenous | mouse
lethal dose (50 percent kill): 2,600 µg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory stimulation
JJPAAZ 3,99,1954
|
intravenous | rat
lethal dose (50 percent kill): 3,600 µg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Dyspnea
DDREDK 5,225,1985
|
ocular | rabbit
lethal dose (50 percent kill): 7,870 µg/kg
|
Eye: Other eye effects | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory stimulation
JTOTDO 2,119,1983
|
oral | human
lowest published lethal dose: 2,857 µg/kg
|
N/R
|
34ZIAG -,191,1969
|
oral | man
lowest published toxic dose: 13,699 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Coma Nutritional and Gross Metabolic: Changes in: Metabolic acidosis
JTCTDW 25,121,1987
|
oral | mouse
lethal dose (50 percent kill): 8,500 µg/kg
|
N/R
|
JPETAB 161,163,1968
|
oral | rat
lethal dose (50 percent kill): 5 mg/kg
|
N/R
|
ARTODN 54,275,1983
|
oral | rat
lethal dose (50 percent kill): 6 mg/kg
|
Behavioral: Tetany | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory obstruction
VCVN1* -,342,1988
|
oral | rabbit
lethal dose (50 percent kill): 5 mg/kg
|
N/R
|
27ZIAQ -,209,1973
|
oral | woman
lowest published toxic dose: 100 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Cardiac: Pulse rate increased without fall in BP Vascular: BP lowering not characterized in autonomic section
AJEMEN 1,94,1983
|
subcutaneous | dog
lethal dose (50 percent kill): 6 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
ATXKA8 21,89,1965
|
subcutaneous | frog
lowest published lethal dose: 60 mg/kg
|
N/R
|
AIPTAK 3,77,1897
|
subcutaneous | guinea pig
lowest published lethal dose: 8 mg/kg
|
N/R
|
CRSBAW 96,202,1927
|
subcutaneous | mouse
lethal dose (50 percent kill): 6,500 µg/kg
|
N/R
|
NYKZAU 54,1057,1958
|
subcutaneous | mouse
lowest published toxic dose: 7 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Convulsions or effect on seizure threshold Biochemical: Metabolism (intermediary): Effect on cyclic nucleotides
TXCYAC 179,29,2002
|
subcutaneous | rat
lethal dose (50 percent kill): 7,814 µg/kg
|
N/R
|
ATSUDG 14,231,1991
|
subcutaneous | rabbit
lethal dose (50 percent kill): 4 mg/kg
|
Lung, Thorax, or Respiration: Other changes
|
JJPAAZ 3,99,1954
|
subcutaneous | rabbit
lethal dose (50 percent kill): 6 mg/kg
|
N/R
|
TOLED5 132,95,2002
|
skin | human
lowest published lethal dose: 80 pph
|
N/R
|
VCVN1* -,342,1988
|
skin | rabbit
lowest published lethal dose: 1 pph/1 hour
|
N/R
|
VCVN1* -,343,1988
|
unreported route | human
lowest published lethal dose: 1.71 mg/kg
|
N/R
|
VCVN1* -,342,1988
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | domestic animal
lowest published toxic dose: 168 mg/kg/20 week- intermittent
|
Brain and Coverings: Other degenerative changes | Spinal Cord: Other degenerative changes
FCTOD7 40,1693,2002
|
intraperitoneal | mouse
lowest published toxic dose: 72 mg/kg/12 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
TOXID9 36(1,pt2),15,1997
|
intraperitoneal | rat
lowest published toxic dose: 21 mg/kg/3 day- intermittent
|
Ear: Change in cochlear structure or function
|
NETEEC 23,157,2001
|
oral | domestic animal
lowest published toxic dose: 483 mg/kg/23 week- intermittent
|
Behavioral: Ataxia | Behavioral: Tremor
FCTOD7 40,1693,2002
|
oral | domestic animal
lowest published toxic dose: 193.2 mg/kg/23 week- intermittent
|
Spinal Cord: Other degenerative changes | Blood: Hemorrhage
FCTOD7 40,1693,2002
|
oral | rat
lowest published toxic dose: 288 mg/kg/30 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Metabolism (intermediary): Effect on mitochondrial function
TSUMEZ 15,219,1996
|
oral | rat
lowest published toxic dose: 31,500 mg/kg/50 week- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Endocrine: Changes in thyroid weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JTEHD6 5,579,1979
|
oral | rat
lowest published toxic dose: 14,420 mg/kg/13 week- continuous
|
Behavioral: Food intake (animal) | Behavioral: Fluid intake Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOLED5 57,195,1991
|
oral | rat
lowest published toxic dose: 4.2 mg/kg/14 day- intermittent
|
Endocrine: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TXCYAC 174,87,2002
|
oral | rat
lowest published toxic dose: 42 mg/kg/14 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Endocrine: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TXCYAC 174,87,2002
|
oral | rat
lowest published toxic dose: 126 mg/kg/14 day- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 174,87,2002
|
oral | rat
lowest published toxic dose: 4.5 mg/kg/15 day- intermittent
|
Endocrine: Evidence of thyroid hypofunction
|
TXCYAC 174,87,2002
|
oral | rat
lowest published toxic dose: 45 mg/kg/15 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Endocrine: Evidence of thyroid hypofunction
TXCYAC 174,87,2002
|
oral | rat
lowest published toxic dose: 135 mg/kg/15 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Endocrine: Evidence of thyroid hypofunction Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 174,87,2002
|
oral | rabbit
lowest published toxic dose: 45 gm/kg/6 week- intermittent
|
Gastrointestinal: Other changes | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
CBPCEE 109,215,1994
|
subcutaneous | mouse
lowest published toxic dose: 84 mg/kg/7 day- intermittent
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Rigidity (includes catalepsy) Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
TXAPA9 126,156,1994
|
subcutaneous | rat
lowest published toxic dose: 11 mg/kg/22 week- intermittent
|
Brain and Coverings: Demyelination | Brain and Coverings: Other degenerative changes
VCVN1* -,343,1988
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
ceiling concentration 5 mg/m3 (skin)
|
DTLVS* TLV/BEI,2002
|
TOXICOLOGY REVIEW
|
|
FNSCA6 2,67,1973
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Cancelled
|
RBREV* -,257,1998
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 5 mg(CN)/m3
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 5 mg(CN)/m3
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 5 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 5 mg(CN)/m3, Skin, JAN1999
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 5 mg(CN)/m3, Skin, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 5 mg(CN)/m3, Skin, JAN1999
|
Occupational Exposure Limit - POLAND
|
time-weighted average 0.3 mg(CN)/m3, CEILING 10 mg(CN)/m3, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 5 mg/m3, KZG- week 10 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 5 mg(CN)/m3, Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | ceiling concentration 5 mg/m3 (skin)
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
ceiling concentration 5 mg/m3 (skin) |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CYANIDE-air
|
ceiling concentration 4.7 ppm(CN)/10 minute
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 60400; | Number of Industries 45; Total Number of Facilities 2,204; Number of Occupations 30; Total Number of Employees Exposed 12,274
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 60400; |
Number of Industries 57; Total Number of Facilities 4,594; Number of Occupations 47; Total Number of Employees Exposed 64,238; Total Number of Female Employees Exposed 23,645 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101207/AS)
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Cyanides (aerosol and gas), 7904
|
|
REFERENCES:
CODEN
|
|
REFERENCE
27ZIAQ
|
"Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G.
Eltherington, Berkeley, Univ. of California Press, 1973
|
34ZIAG
|
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AJEMEN
|
American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ATSUDG
|
Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) No.1- 1978-
|
ATXKA8
|
Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher
information, see ARTODN.
|
BNEOBV
|
Biology of the Neonate. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.15-
1970-
|
CBPCEE
|
Comparative Biochemistry and Physiology, C: Pharmacology, Toxicology and Endocrinology.
(Elsevier Science, 660 White Plains Rd., Tarrytown, NY 10591) V.74- 1983-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CRSBAW
|
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22,
F-41353 Vineuil, France) V.1- 1849-
|
DDREDK
|
Drug Development Research. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1-
1981-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EKFAE9
|
Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology.
(Mezhdunarodnaya Kniga, ul. B. Yakimanka, 39, 117049 Moscow, Russia) V.55- 1992-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
FNSCA6
|
Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see
FSINDR.
|
JACTDZ
|
Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New
York, NY 10128) V.1-12, 1982-1993. Discontinued.
|
JAPYAA
|
Journal of Applied Physiology. (Bethesda, MD) V.1-41, 1948-76.
|
JJPAAZ
|
Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology,
Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JTCTDW
|
Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY
10016) V.19- 1982-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
JTOTDO
|
Journal of Toxicology, Cutaneous and Ocular Toxicology. (Marcel Dekker, 270 Madison Ave., New
York, NY 10016) V.1- 1982-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NEOLA4
|
Neoplasma. (Karger-Libri, P.O. Box, CH-4009 Basel, Switzerland) V.4- 1957-
|
NETEEC
|
Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.9- 1987-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NYKZAU
|
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto
Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40-
1944-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
RJARAV
|
Rhodesian Journal of Agricultural Research. (Salisbury, Rhodesia) V.1-17, 1963-79.
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TSUMEZ
|
Toxic Substance Mechanisms. (Taylor & Francis, 1900 Frost Rd., Suite 101, Bristol, PA 19007)
V.14- 1995-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VCVN1*
|
"Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous
substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988.
|
|